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In response to the outbreak of Covid-19, temporary amendments to the Medicinal Products 
(Prescription and Control of Supply) Regulations 2003 (as amended)1 and the Misuse of Drugs 
Regulations 2017 (as amended)2 have been made by the Minister for Health.  
These temporary provisions are designed to ensure that patients can continue to access their 
ongoing treatment and ‘regular’ medicines during the ongoing emergency and to assist in easing the 
additional burdens on prescribers and pharmacists arising from the pandemic. These amendments 
will be referred to in this document as ‘Covid-19 Emergency Provisions’. 
Who is this guidance for? 
 
This guidance is for pharmacists and prescribers as well as other healthcare workers and pharmacy 
staff who need to familiarise themselves with recent changes in legislation in response to the Covid-
19 pandemic.  
What has been changed? 
 
The amendments allow for the electronic transfer of prescriptions between doctors and pharmacies 
and remove the need for a paper equivalent.  
The legislation also extends the validity of prescriptions from six to nine months and enables 
pharmacists to make additional supplies of prescription only medicines to patients from an existing 
prescription.  This additional authority to pharmacists must only be used where, in the pharmacist’s 
professional judgement, continued treatment is required and it is safe and appropriate to make an 
additional supply. 
This extension of authority places an important duty on the pharmacist to use their professional 
judgement in discussing the patient’s treatment with them, so as to ensure that it is safe, 
appropriate and necessary for their continued treatment and care for further supplies to be made. 
Changes have also been made to the quantity of medicine that can be provided as an emergency 
supply at the request of a patient or prescriber. 
Collaboration between prescriber and pharmacist remains vital, and the pharmacist should contact 
the prescriber to discuss the patient’s care if in doubt as to whether it is the intention of the 
prescriber for a continued supply of a medicine to be made, or the pharmacist wishes to obtain 
further information on whether it is safe or in the patient’s best interest to do so.  
                                                          
1 The Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations 2020 
2The Misuse of Drugs (Amendment) Regulations 2020 
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Section A - Key Changes under Covid-19 Emergency Provisions 
 
The table below provides an overview of the key changes under the Covid-19 Emergency Provisions.  
Electronic 
Prescription 
Transfer 
Under the Covid-19 Emergency Provisions, the National electronic prescription 
transfer system will permit the transfer of a prescription between the prescriber and 
dispensing pharmacy by electronic means. Users are issued with a healthmail account 
(@healthmail.ie email account) and this will allow them to communicate patient 
identifiable clinical information with clinicians in primary and secondary care.  
 
This includes prescriptions for Schedule 2, 3 and 4 Controlled Drugs.  
 
To be legally valid the prescription must: 
- be in electronic form,  
- be transmitted by the national electronic prescription transfer system (see 1.0 for 
further details), 
- clearly indicate the date of issue, 
- clearly indicate the professional registration number of the prescriber, and 
- be traceable electronically back to the prescriber. 
 
All other prescription requirements under the relevant legislation must still be met. 
 
The pharmacy must print a copy of the prescription as transmitted and treat it as an 
original prescription for the purposes of record-keeping, reimbursement and also to 
assist with dispensing preparation and checking.  
 
A prescription sent outside the National electronic prescription transfer system is not 
recognised in the legislation as a legally valid prescription, for example, prescriptions 
sent through personal or commercial email accounts or fax. 
A pharmacy can send the prescription to another pharmacy for subsequent 
dispensing/supply using healthmail.  
 
For Schedule 2 or 3 Controlled Drug prescriptions the prescription writing 
requirements still apply, however these do not need to be in the prescriber’s own 
handwriting. 
 
How long a 
prescription 
is valid for 
The maximum period of validity of a prescription for a human medicinal product is 
now 9 months from the date specified on the prescription (previously 6 months). This 
is only where in the pharmacist’s professional judgement, after consultation with the 
patient, and if needs be the prescriber, continued treatment is required and it is safe 
and appropriate to do so.  
 
Please note the validity of prescriptions for Schedule 2 or 3 Controlled Drugs is 
unchanged i.e. supply cannot be made later than 14 days after the date on the 
prescription.  
 
Validity of prescriptions for a Schedule 2 or 3 Controlled Drug to be dispensed in 
instalments is also unchanged i.e. the first instalment must be dispensed within 14 
days of the date stated on the prescription and no instalment shall be supplied later 
than 2 months after the date specified on the prescription.  
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Additional supplies may be made against prescriptions that had been dispensed in full 
prior to the Covid-19 Emergency Provisions (see 2.2 for details). 
 
 
Repeat 
Supply 
The number of times a prescription may be repeated has been increased. 
 
How many repeats may be supplied varies depending on the type of medicinal 
product (i.e. S1A ‘non-renewable’ e.g. antidepressants and hypnotics or S1B-
‘renewable’ e.g. medicinal products for chronic conditions including blood pressure, 
diabetes or asthma) and the dispensing instructions of the original prescription (the 
number of occasions it may be repeated or intervals such as weekly, monthly etc.) 
(See 3.1 and 3.2 for details). 
 
This does not include prescriptions for Schedule 2 or 3 Controlled Drugs which 
cannot be repeated. It also excludes prescriptions for Schedule 4 Controlled Drugs 
which may only be repeated if specified by the prescriber. 
 
The pharmacist must use their professional judgement, in consultation with the 
patient, and if needs be the prescriber, to ensure that it is safe, appropriate and 
necessary to provide additional supplies of a medication for the patient’s continued 
treatment and care. The intention of the legislation is not to enable additional 
supplies of a medicine for acute treatment such as a short-term antibiotic.   
 
Emergency 
Supply (at 
the request 
of a 
prescriber) 
A prescriber can request a pharmacist to make an ‘emergency supply’ of a 
prescription only medicinal product to a patient where by reason of an emergency, 
he or she is not in a position to provide the prescription immediately.  
 
Where a prescriber makes a request for an emergency supply for their patient, they 
must undertake to provide the prescription to the pharmacy within 72 hours. 
 
In addition, under the Covid-19 Provisions, a pharmacist is permitted to supply a 
Schedule 2, 3 or 4 Controlled Drug at the request of a prescriber where: 
- it is unreasonable at the time of supply, in the circumstances arising from the 
Covid-19 emergency, for the person to obtain a new prescription for that 
medicinal product,  
- it is in the opinion of the pharmacist that it is safe, appropriate and necessary for 
the continued treatment of the person for an emergency supply to be made, 
and 
- no greater quantity of the product than will provide 5 days’ treatment is 
supplied. 
 
A prescriber can also request an emergency supply in the circumstances arising from 
the Covid-19 emergency of the following Schedule 4 Part 1 Controlled Drugs - 
midazolam, clobazam and clonazepam for the treatment of epilepsy. 
Emergency 
Supply (at 
the request 
Under the Covid-19 Emergency Provisions, a pharmacist can dispense at the request 
of a patient an ‘emergency supply’ of: 
- up to 10 days’ supply of a prescription only medicinal product where the 
treatment has been prescribed for the patient on a previous occasion.   
- up to 5 days’ supply of a Schedule 2, 3 or 4 Controlled Drug where it is 
unreasonable at the time of supply, in the circumstances arising from the Covid-
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of a 
patient) 
 
 
 
 
19 emergency, for the person to obtain a new prescription for that medicinal 
product,  
- it is in the opinion of the pharmacist that it is safe, appropriate and necessary for 
the continued treatment of the person for an emergency supply to be made,  
- up to 10 days’ supply of the following Schedule 4 Part 1 Controlled Drugs: 
midazolam, clobazam and clonazepam for the treatment of epilepsy. 
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Repeat Supply of S1A Medicinal Products – Summary of Key Changes 
under Covid-19 Emergency Provisions  
Repeat Supply of S1A Medicinal Products (Classified as ‘Non-renewable’ by the HPRA e.g. 
antidepressants and hypnotics) 
 Key Change Pre-existing legislation 
Prescription (for an S1A 
medicinal product excluding 
Schedule 2, 3 or 4 Part 1 
Controlled Drug) does not 
state the number of occasions 
(e.g. repeat x 6), nor the 
intervals (e.g. monthly, 
weekly). 
May be dispensed on one additional 
occasion, where it is the opinion of the 
pharmacist that it is appropriate and 
necessary for the continued treatment 
of the person for further supply to be 
made and it is unreasonable at the time 
of supply, in the circumstances arising 
from the Covid-19 emergency, for the 
person to obtain a new prescription for 
that medicinal product. 
Previously under these 
circumstances S1A 
medicinal products could 
only be dispensed on one 
occasion. 
Prescription (for an S1A 
medicinal product excluding 
Schedule 2, 3 or 4 Part 1 
Controlled Drug) is a health 
prescription (e.g. a GMS 
standard prescription) and is 
not ordinarily endorsed to be 
repeated. 
May be dispensed on no more than 
four occasions where it is the opinion 
of the pharmacist that it is appropriate 
and necessary for the continued 
treatment of the person for further 
supplies to be made. 
Previously under these 
circumstances health 
prescriptions for S1A 
medicinal products could 
only be dispensed on one 
occasion. 
Prescription (for an S1A 
medicinal product) states the 
intervals that a medicinal 
product can be supplied, but 
omits the number of 
occasions. 
May be dispensed on no more than 
four occasions. 
Previously under these 
circumstances S1A 
medicinal products could 
be dispensed on no more 
than three occasions. 
Prescription (for an S1A 
medicinal product) states the 
number of occasions that a 
medicinal product can be 
supplied but omits the 
intervals. 
May be dispensed on the number of 
occasions indicated on the prescription, 
at such intervals that the pharmacist 
considers appropriate, having regard to 
the specified dose rate and the 
maximum 9 month validity period of 
the prescription under the Covid-19 
Emergency Provisions. 
This provision remains 
unchanged, however the 
validity of prescriptions 
has changed from 6 to 9 
months. 
The number of occasions 
specified on the prescription 
(for an S1A medicinal product) 
has been reached. 
May be dispensed on three further 
occasions where in the opinion of the 
pharmacist it is appropriate and 
necessary for the continued treatment 
of the person for further supplies to be 
made. 
Previously in these 
circumstances the 
prescription could not be 
repeated on further 
occasions. 
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Repeat Supply of S1B Medicinal Products – Summary of Key Changes 
under Covid-19 Emergency Provisions 
 
Repeat Supply: S1B Medicinal Products (Classified as ‘Renewable’ by the HPRA e.g. medicinal 
products for chronic conditions including blood pressure, diabetes or asthma) 
 Key changes Pre-existing legislation 
Prescription (for an S1B 
medicinal product) does not 
state the number of occasions 
(e.g. repeat x 6) nor the 
intervals (e.g. monthly, 
weekly) that the product may 
be supplied. 
May be supplied by the pharmacist for 
up to 9 months, on the number of 
occasions that the pharmacist deems 
appropriate, where it is in their opinion 
that it is appropriate and necessary for 
the continued treatment of the patient. 
Previously the pharmacist 
could make the supply for 
up to 6 months. 
Prescription (for an S1B 
medicinal product) states the 
number of intervals that a 
product can be supplied but 
omits the number of 
occasions. 
May be dispensed for up to 9 months, 
at the intervals stated on the 
prescription. 
Previously the pharmacist 
could make the supply for 
up to 6 months. 
Prescription (for an S1B 
medicinal product) states the 
number of occasions that a 
product can be supplied but 
omits the intervals. 
May be dispensed at such intervals that 
the pharmacist considers appropriate, 
having regard to the specified dose rate 
and the maximum 9 month validity 
period of the prescription under the 
Covid-19 Emergency Provisions. 
This provision remains 
unchanged, however the 
validity of prescriptions 
has changed from 6 to 9 
months. 
The number of occasions 
specified on the prescription 
(for an S1B medicinal product) 
has been reached. 
May be dispensed on three further 
occasions where in the opinion of the 
pharmacist it is appropriate and 
necessary for the continued treatment 
of the person for further supplies to be 
made. 
Previously in these 
circumstances the 
prescription could not be 
repeated on further 
occasions. 
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Section B – Guidance on Covid-19 Emergency Provisions 
 
This section provides more detailed guidance on the Covid-19 Emergency Provisions. Where 
relevant, the pre-existing legal position is provided in italics in order to be clear about the change to 
legislation. 
 
1. Electronic Prescription Transfer  
The legislation allows for a prescription to be transferred via a ‘national electronic prescription 
transfer system’, in a permanent and unalterable form, by electronic means approved, on behalf of 
the Health Service Executive, by the head of the Primary Care Reimbursement Service (PCRS) and 
the Chief Information Officer. Further information on this system will be available at 
www.healthmail.ie. 
 
To meet the requirements for a legally valid prescription via the national electronic prescription 
transfer system, the prescription must:  
 be in an unalterable electronic form,  
 be transmitted by the national electronic prescription transfer system,  
 clearly indicate the date of issue, 
 clearly indicate the professional registration number of the prescriber3, and 
 be traceable electronically back to the prescriber. 
 
All other prescription requirements under the relevant legislation must still be met. 
 
In practice, this will enable prescribers to send prescriptions to a patient’s chosen pharmacy using 
the secure clinical email system ‘Healthmail’4. Healthmail has been specially developed to allow 
clinical patient information to be sent and received by healthcare providers in a secure manner. 
Healthmail may also be a useful means to address prescription queries to GPs. 
 
Depending on the prescriber’s software system, some prescribers will be able to send prescriptions 
directly from their prescribing module to Healthmail. If this is not possible the prescriber may print 
the prescription, scan it, and send it as an attachment via Healthmail.   
 
In all cases where Healthmail is used to send prescriptions, the prescriber needs to know the 
Healthmail address of the pharmacy that the patient intends to use.  
 
- If you have not done so already you can register for a Healthmail account at 
www.healthmail.ie/ 
 
Where a prescription is provided using the national electronic prescription transfer system there is 
no need to obtain the paper equivalent from the prescriber. However, the pharmacy must print a 
copy of the prescription as transmitted and treat it as an original prescription for the purposes of 
                                                          
3 The professional registration number refers to the registration number provided by the relevant legislation to 
the medical practitioner, dentist or nurse. 
4 Healthmail is a service of the Primary Care Directorate of the HSE, managed by eHealth Ireland and 
supported by the Irish College of General Practitioners, the Irish Pharmacy Union, Nursing Homes Ireland and 
the Association of Optometrists Ireland. 
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record-keeping and reimbursement5, and to assist with dispensing preparation and checking. An 
electronic version of the prescription must also be retained.  
 
All prescription only medicinal products can be prescribed using the national electronic prescription 
transfer system including Schedule 2, 3 and 4 Controlled Drugs. Where a Schedule 2 or 3 Controlled 
Drug is prescribed using the national electronic prescription transfer system the prescription writing 
requirements still apply, however, these do not need to be in the prescriber’s own handwriting6.  
 
It should be noted that the electronic presentation of patient information by any other non-
approved mechanism is not recognised in the legislation as a legally valid prescription (e.g. an email 
sent from a personal or commercial email account, or a fax).  Faxed prescriptions and medication 
charts (or copies thereof) are only to be used in the support of an emergency request, and not as 
valid prescriptions. 
 
2. Validity Period of Prescriptions  
2.1 Under the Covid-19 Emergency Provisions, the maximum period of validity of a prescription for a 
human medicinal product (excluding a prescription for a Schedule 2 or 3 Controlled Drug) is 9 
months from the date specified on the prescription. The pharmacist must use their professional 
judgement, in consultation with the patient, and if needs be the prescriber, to ensure that it is safe, 
appropriate and necessary to provide additional supplies of a medication, for the patient’s continued 
treatment and care. 
Previously a prescription for a prescription only medicinal product was valid for 6 months from the 
date specified on the prescription. 
Please note the validity of prescriptions for Schedule 2 or 3 Controlled Drugs is unchanged i.e. a 
supply cannot be made later than 14 days after the date on the prescription. Validity for a Schedule 
2 or 3 Controlled Drug prescription to be dispensed in instalments is also unchanged i.e. the first 
instalment must be dispensed within 14 days of the date stated on the prescription and no 
instalment shall be supplied later than 2 months after the date specified on the prescription. 
2.2 For prescriptions that have been dispensed in full (marked with the word ‘dispensed’ and the 
date on which it was dispensed), prior to the Covid-19 Emergency Provisions coming into force, the 
pharmacist may make additional supplies against the prescription subject to the requirements for 
repeat dispensing of S1A and S1B medicinal products set out in 3.1 and 3.2 below. 
Previously once a prescription was dispensed in full no further supplies were permitted using that 
prescription. 
 
  
                                                          
5 For pharmacies that put in manual claims to PCRS a copy of the electronic prescription can be printed off and 
included in the paper bundle. 
6 Page 7 of the PSI and Medical Council joint guidance on Safe Prescribing and Dispensing of Controlled Drugs 
sets out the prescription writing requirements for Schedule 2 and 3 Controlled Drugs. 
Version 1 - April 2020 
 
 
3.  Repeat Supply  
Under the Covid-19 Emergency Provisions, the general procedures which must be adhered to when 
issuing a repeat supply of an S1A or S1B medicinal product to a patient on foot of a prescription from 
a medical practitioner are set out below. The tables above provide a summary of the key changes for 
ease of reference. 
 
The pharmacist must use their professional judgement, in consultation with the patient, and if needs 
be the prescriber, to ensure that it is safe, appropriate and necessary to provide additional supplies 
of a medication for the patient’s continued treatment and care. The intention of the legislation is not 
to enable additional supplies of a medicine for acute treatment such as a short term antibiotic.   
 
It is also important at this time that patients should not order, and pharmacists should not supply, 
over and above normal quantities of medicines, in order to avoid disruption to the supply of 
medicines for other patients.  
 
3.1 S1A Medicinal Products (S1A medicinal products are classified as ‘Non-renewable’ by the 
HPRA e.g. antidepressants and hypnotics).  
3.1.1 If a prescription for an S1A medicinal product does not state the number of occasions (e.g. 
repeat x 6), nor the intervals (e.g. monthly, weekly) that the medicinal product may be supplied, S1A 
medicinal products can be dispensed on one additional occasion, where it is the opinion of the 
pharmacist that it is appropriate and necessary for the continued treatment of the person for  
further supply to be made and it is unreasonable at the time of supply, in the circumstances arising 
from the Covid-19 emergency for the person to obtain a new prescription for that medicinal 
product.  
This excludes Controlled Drugs in Schedule 2 and 3; prescriptions for these medicinal products 
cannot be repeated. It also excludes Schedule 4 Part 1 Controlled Drugs prescriptions; these can 
only be repeated if specified by the prescriber.  
Previously under these circumstances S1A medicinal products could only be dispensed on one 
occasion. 
3.1.2 If the prescription is a health prescription (e.g. a GMS prescription), and is not ordinarily 
endorsed to be repeated, S1A medicinal products can be dispensed on no more than four occasions 
where it is the opinion of the pharmacist that it is appropriate and necessary for the continued 
treatment of the person for further supplies to be made.  
 
This excludes Controlled Drugs in Schedule 2 and 3; prescriptions for these medicinal products 
cannot be repeated. It also excludes Schedule 4 Part 1 Controlled Drugs prescriptions; these can 
only be repeated if specified by the prescriber. 
Previously under these circumstances health prescriptions for S1A medicinal products could only be 
dispensed on one occasion.  
 
3.1.3 If the prescription states the intervals that a medicinal product can be supplied, but omits the 
number of occasions, S1A medicinal products can be dispensed on no more than four occasions. 
Version 1 - April 2020 
 
 
Previously under these circumstances S1A medicinal products could be dispensed on no more than 
three occasions.  
3.1.4 If the prescription states the number of occasions that a medicinal product can be supplied, 
but omits the intervals, S1A medicinal products can be dispensed on the number of occasions 
indicated on the prescription, at such intervals that the pharmacist considers appropriate, having 
regard to the specified dose rate and the maximum 9 month validity period of the prescription 
under the Emergency Covid-19 Emergency Provisions. 
This provision remains unchanged, however the validity of prescriptions has changed from 6 to 9 
months. 
3.1.5 Where the number of occasions specified on the prescription has been reached, the 
prescription may be dispensed on three further occasions where in the opinion of the pharmacist it 
is appropriate and necessary for the continued treatment of the person for further supplies to be 
made. 
Previously in these circumstances the prescription could not be repeated on further occasions. 
3.2 S1B Medicinal Products (S1B medicinal products are classified as ‘Renewable’ by the HPRA 
e.g. medicinal products for chronic conditions including blood pressure, diabetes or asthma)  
3.2.1 If the prescription does not state the number of occasions (e.g. repeat x 6) nor the intervals 
(e.g. monthly, weekly) that the product may be supplied, S1B medicinal products may be supplied by 
the pharmacist for up to 9 months, on the number of occasions that the pharmacist deems 
appropriate, where it is in their opinion that it is appropriate and necessary for the continued 
treatment of the patient. 
 
Previously the pharmacist could make the supply for up to 6 months. 
 
3.2.2 If the prescription states the number of intervals that a product can be supplied but omits the 
number of occasions, S1B medicinal products can be dispensed for up to 9 months, at the intervals 
stated on the prescription. 
 
Previously the pharmacist could make the supply for up to 6 months. 
3.2.3 If the prescription states the number of occasions that a product can be supplied, but omits the 
intervals, S1B medicinal products can be dispensed at such intervals that the pharmacist considers 
appropriate, having regard to the specified dose rate and the maximum 9 month validity period of 
the prescription under the Emergency Covid-19 Emergency Provisions. 
This provision remains unchanged, however the validity of prescriptions has changed from 6 to 9 
months. 
3.2.4 Where the number of occasions specified on the prescription has been reached, the 
prescription may be dispensed on three further occasions where in the opinion of the pharmacist it 
is appropriate and necessary for the continued treatment of the person for further supplies to be 
made. 
Previously in these circumstances the prescription could not be repeated on further occasions. 
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4. Emergency Supply of Prescription Only Medicinal Products 
The current legislation permits pharmacists, in emergency circumstances, to supply certain 
prescription only medicines without a prescription. Emergency supply can be carried out at the 
request of a patient or at the request of a prescriber.  
 
4.1 Emergency Supply at the Request of a Patient 
 
4.1.1 Under the Covid-19 Emergency Provisions, a pharmacist can dispense up to 10 days’ supply of a 
prescription only medicinal product at the request of a patient.   
 
As previously required when supplying a medicine under these provisions, the pharmacist must be 
satisfied that: 
 there is an immediate need for the medicine to be supplied and it is impracticable to obtain a 
prescription without undue delay, 
 the treatment has been prescribed for the patient on a previous occasion, and 
 they can safely specify the dose of the medicine for the patient. 
 
4.1.2 In addition, under the Covid-19 Provisions, a pharmacist is permitted to supply a Schedule 2, 3 
or 4 Controlled Drug at the request of a patient where: 
 it is unreasonable at the time of supply, in the circumstances arising from the Covid-19 
emergency, for the person to obtain a new prescription for that medicinal product,  
 it is in the opinion of the pharmacist that it is safe, appropriate and necessary for the 
continued treatment of the person for an emergency supply to be made, and  
 no greater quantity of the product than will provide 5 days’ treatment is supplied. 
 
4.1.3 A pharmacist can also make an emergency supply, in the circumstances arising from the Covid-
19 emergency, of up to 10 days’ supply of the following Schedule 4 Part 1 Controlled Drugs: 
midazolam, clobazam and clonazepam for the treatment of epilepsy. 
Previously no more than a 5 day supply could be made of a prescription only medicinal product at the 
request of a patient, and an emergency supply of a Controlled Drug in Schedule 2, 3 or 4 was not 
permitted, with the exemption of phenobarbitone supplied for the treatment of epilepsy. 
 
As before, a pharmacist may also supply the following at the request of a patient: 
 the smallest available size of an aerosol, cream or ointment,  
 a full cycle of the oral contraceptive pill,  
 the smallest quantity of an antibiotic that will provide a complete course.  
 
4.2 Emergency supply at the request of a prescriber 
 
4.2.1 A prescriber can request an emergency supply of a prescription only medicinal product where 
by reason of an emergency, he or she is not in a position to provide the prescription immediately. 
Where a prescriber makes a request for an emergency supply for their patient, they must undertake 
to provide the prescription to the pharmacy within 72 hours. 
4.2.2 In addition, under the Covid-19 Provisions, a pharmacist is permitted to supply a Schedule 2, 3 
or 4 Controlled Drug at the request of a prescriber where: 
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 it is unreasonable at the time of supply, in the circumstances arising from the Covid-19 
emergency, for the person to obtain a new prescription for that medicinal product,  
 it is in the opinion of the pharmacist that it is safe, appropriate and necessary for the 
continued treatment of the person for an emergency supply to be made, and  
 no greater quantity of the product than will provide 5 days’ treatment is supplied. 
4.2.3 A prescriber can also request an emergency supply in the circumstances arising from the Covid-
19 emergency, of the following Schedule 4 Part 1 Controlled Drugs: midazolam, clobazam and 
clonazepam for the treatment of epilepsy.  
Legislation does not limit the quantity of these Schedule 4 Part 1 Controlled Drugs that may be 
supplied at the request of a prescriber in these circumstances, however, the pharmacist should be 
satisfied that the quantity requested is safe and appropriate for the patient at that point in time. 
Previously an emergency supply of a Controlled Drug in Schedule 2, 3 or 4 at the request of a 
prescriber could not be made, with the exemption of phenobarbitone supplied for the treatment of 
epilepsy. 
 
5. Record Keeping Requirements  
5.1 For prescriptions that are dispensed in compliance with the Covid-19 Emergency Provisions, for 
example in circumstances outlined in 3.0 above, and the original prescription is not available (for 
example a GMS standard or GMS repeat prescription that has been sent to PCRS for payment), the 
requirement to mark the prescription with the quantity and date of supply of each medicinal 
product and the name and address of the pharmacy does not apply.   
In these circumstances the pharmacist must make a record of the reasons for making the supply 
under the Covid-19 Emergency Provisions as part of the prescription register (i.e. daily audit report).  
This record must be retained on the pharmacy premises for a period of two years from the date of 
supply and be readily available for inspection. 
 
5.2 Where a prescription is received via the national electronic prescription transfer system, the 
pharmacist must print the prescription as transmitted and treat it as an original prescription for the 
purposes of record keeping. This means that the printout must be marked at each supply in the normal 
way, with the quantity and date of supply of each medicinal product and the name and address of the 
pharmacy. Where a prescription is dispensed in full, the printout must be marked with the word 
‘dispensed’ and the date on which it was dispensed. The prescription can be forwarded to another 
pharmacy if needs be using healthmail. 
 
All printouts of prescriptions transmitted via the national electronic prescription transfer system, as 
well as an electronic version of the prescription, must be retained for a period of two years on the 
pharmacy premises and be readily available for inspection. The retention period begins from the date 
on which the medicinal product was supplied, or for repeatable prescriptions from the date on which 
the prescription was dispensed for the last time. 
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Appendix 1: Controlled Drug Prescription Requirements – Key 
Changes under Covid-19 Emergency Provisions 
 
Key changes for Controlled Drug Prescription Requirements (Covid 19) 
 Schedule 2 or 3 Controlled Drugs Schedule 4 Part 1 Controlled Drugs 
The transfer of a 
prescription between 
the prescriber and 
dispensing pharmacy by 
electronic means is 
allowed using the 
national electronic 
prescription transfer 
system 
✓ ✓ 
When a prescription is 
transferred by 
electronic means, the 
requirements that 
elements of 
theprescription be 
handwritten do not 
apply 
✓ ✓ 
Schedule 2 or 3 Controlled Drug 
prescription writing requirements still 
apply, however these do not need to 
be in the prescriber’s own 
handwriting. 
As in previous legislation, not required 
to be handwritten. 
Repeat Prescriptions 
Acceptable 
 
✘ 
As in previous legislation Schedule 2 
or 3 Controlled Drug prescriptions 
cannot be repeated. 
 
✓ 
As in previous legislation Schedule 4 
Part 1 Controlled Drug prescriptions 
may only be repeated if specified by 
the prescriber. 
 As in previous legislation Schedule 4 
Part 1 Controlled Drug prescriptions 
may only be repeated if specified by 
the prescriber. 
Validity of prescriptions Remains at 14 days i.e. a supply 
cannot be made later than 14 days 
after the date on the prescription. 
The maximum period of validity of a 
prescription for a Schedule 4 Part 1 
Controlled Drug is 9 months from the 
date specified on the prescription. 
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Emergency supply at 
the request of a patient 
permitted 
✓ 
 
Under the Covid-19 Provisions, a pharmacist is permitted to supply a 
Schedule 2, 3 or 4 Controlled Drug at the request of a patient where: 
 it is unreasonable at the time of supply, in the circumstances 
arising from the Covid-19 emergency, for the person to obtain a 
new prescription for that medicinal product,  
 it is in the opinion of the pharmacist that it is safe, appropriate 
and necessary for the continued treatment of the person for an 
emergency supply to be made, and  
 no greater quantity of the product than will provide 5 days’ 
treatment is supplied.  
Emergency supply at 
the request of a 
prescriber permitted 
✓ 
 
 
 
Under the Covid-19 Provisions, a pharmacist is permitted to supply a 
Schedule 2, 3 or 4 Controlled Drug at the request of a prescriber where: 
• it is unreasonable at the time of supply, in the 
circumstances arising from the Covid-19 emergency, for the 
person to obtain a new prescription for that medicinal 
product,  
• it is in the opinion of the pharmacist that it is safe, 
appropriate and necessary for the continued treatment of 
the person for an emergency supply to be made, and  
• no greater quantity of the product than will provide 5 days’ 
treatment is supplied. 
 
Prescriber must provide the prescription to the pharmacy within 72 
hours. 
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